Consensus Calumet Specialty Products Partners, L.P.

Equities

CLMT

US1314761032

Market Closed - Nasdaq 04:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
15.67 USD +0.58% Intraday chart for Calumet Specialty Products Partners, L.P. +3.43% -12.31%

Evolution of the average Target Price on Calumet Specialty Products Partners, L.P.

Price target over the last 5 years

History of analyst recommendation changes

d0faf7890d1.qqLLWdnfqCKrCBO75oPH799vOWDFw8nX5xJeU5S7Ehg.-s-kFqu-8UqZf2rO1fSCjOtYABeds4Pk02ozZKX4XCD9lvMevebdeshKZA~74678d13dad86d10fac285af1078e124
Goldman Sachs Adjusts Calumet Specialty Products Partners' Price Target to $17 From $19, Keeps Buy Rating MT
Goldman Sachs Adjusts Price Target on Calumet Specialty Products Partners to $19 From $17, Maintains Buy Rating MT
Goldman Sachs Adjusts Calumet Specialty Products Partners' Price Target to $17 From $19, Keeps Buy Rating MT
UBS Adjusts Calumet Specialty Products Partners Price Target to $19 From $21, Maintains Neutral Rating MT
Goldman Sachs Lifts Price Target on Calumet Specialty Products Partners to $19 From $18, Keeps Buy Rating MT
Goldman Sachs Trims Price Target on Calumet Specialty Products Partners to $19 From $20, Maintains Buy Rating MT
UBS Adjusts Calumet Specialty Products' Price Target to $19.50 From $18.50, Maintains Neutral Rating MT
TD Cowen Adjusts Price Target on Calumet Specialty Products Partners to $23 From $21, Maintains Outperform Rating MT
Wells Fargo Adjusts Price Target on Calumet Specialty Products Partners to $27 From $29, Maintains Overweight Rating MT
UBS Adjusts Calumet Specialty Products Partners Price Target to $18.50 From $17, Maintains Neutral Rating MT
Goldman Sachs Trims Price Target on Calumet Specialty Products Partners to $22 From $23 to Reflect Updated Estimates, Keeps Buy Rating MT
HC Wainwright Adjusts Price Target on Calumet Specialty Products Partners to $25 From $28, Maintains Buy Rating MT
UBS Adjusts Calumet Specialty Products Partners' Price Target to $17 From $15.70, Keeps Neutral Rating MT
UBS Initiates Coverage on Calumet Specialty Products Partners With Neutral Rating, $15.70 Price Target MT
Cowen Raises Calumet Specialty Products Partners Price Target to $23 From $20, Maintains Outperform Rating MT
Wolfe Research Raises Calumet Specialty Products Partners Price Target to $36 From $31, Maintains Outperform Rating MT
Goldman Sachs Upgrades Calumet Specialty Products Partners to Buy From Neutral, Raises PT to $23 From $14 MT
Cowen Adjusts Price Target on Calumet Specialty Products Partners to $20 From $18, Keeps Outperform Rating MT
Goldman Sachs Lowers PT for Calumet Specialty Products to $14 From $15.50 to Reflect Reduced Multiples, Maintains Neutral Rating MT
Cowen Adjusts Calumet Specialty Products Partners' Price Target to $20 from $18, Keeps Outperform Rating MT
Wells Fargo Raises Calumet Specialty Products Partners Price Target to $29 From $27, Maintains Overweight Rating MT
HC Wainwright Adjusts Price Target on Calumet Specialty Products Partners to $28 From $19, Maintains Buy Rating MT
Goldman Sachs Raises Price Target on Calumet Specialty Products Partners to $15.50 From $14.50, Maintains Neutral Rating MT
Wolfe Research Downgrades Calumet Specialty Products Partners to Peerperform From Outperform, Keeps $30 Price Target MT
Credit Suisse Starts Calumet Specialty Products Partners at Neutral with $23 PT, Says Transformation Implies 'Significant' Earnings Growth Potential MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
15.58 USD
Average target price
22.25 USD
Spread / Average Target
+42.81%
High Price Target
29 USD
Spread / Highest target
+86.14%
Low Price Target
17 USD
Spread / Lowest Target
+9.11%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Calumet Specialty Products Partners, L.P.

Goldman Sachs
UBS
TD Cowen
Wells Fargo Securities
HC Wainwright
Cowen
Wolfe Research
Credit Suisse
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
  1. Stock Market
  2. Equities
  3. CLMT Stock
  4. Consensus Calumet Specialty Products Partners, L.P.